CLINICAL_TRIALS
trial_result
· 2021-01-07
Clinical Trial Update: Efficacy and Safety of DLBS2411 in the Management of GERD [Phase 3]
Summary
Phase 3 trial update for DLBS2411 in gastroesophageal reflux disease (GERD) evaluating efficacy and safety; study status terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dexa Medica Group | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 3 | Status: TERMINATED